Adenomyosis and Fertility: Diagnosis, IVF Questions, and What the Evidence Can—and Cannot—Tell You

Adenomyosis is increasingly recognized during fertility imaging, but the evidence is less settled than many clinic websites imply. Ultrasound and MRI can support diagnosis, and adenomyosis may be associated with reduced reproductive outcomes in some populations. There is not yet one universally proven pre-IVF treatment pathway for every patient.

What adenomyosis is

Adenomyosis is a condition in which endometrial-type tissue is found within the muscular wall of the uterus. It can be diffuse or focal, and its imaging appearance can overlap with fibroids and other uterine findings.

Some people have heavy bleeding, painful periods, pelvic pressure, or an enlarged tender uterus. Others have no obvious symptoms and first hear the term after a fertility ultrasound or MRI.

How fertility clinics diagnose it

Transvaginal ultrasound is usually the first-line tool. Experienced sonographers look for a collection of features rather than one magic sign. MRI can be useful when ultrasound is inconclusive, anatomy is complex, or a surgeon needs more detailed mapping.

ESHRE has been developing good-practice recommendations specifically because terminology and diagnostic criteria have varied substantially across studies. That variation is important: a study of severe diffuse adenomyosis may not apply to a patient with a subtle focal imaging finding.

What it may mean for conception and IVF

Observational studies have associated adenomyosis with infertility, miscarriage, and lower ART success in some groups, but the size of the effect varies. Age, endometriosis, embryo quality, disease severity, prior surgery, and how adenomyosis was diagnosed can all confound the result.

This is why a diagnosis should lead to a structured conversation rather than an automatic treatment protocol. Ask whether the finding is mild or extensive, focal or diffuse, symptomatic or incidental, and whether it changes the clinic’s transfer strategy.

Treatment before embryo transfer is not one-size-fits-all

Hormonal suppression before frozen embryo transfer is used by some clinics, particularly for more extensive disease, but duration and patient selection vary and high-quality evidence is still developing. Surgery may be appropriate for selected focal disease or major symptoms, but uterine surgery has its own reproductive tradeoffs.

If ovarian reserve is a concern, treatment sequencing matters. A patient may need to discuss whether to retrieve and bank embryos before months of suppression or uterine treatment.

A useful decision framework

Confirm that the diagnosis is based on appropriate imaging rather than a vague note.
Ask how severe and how extensive the finding appears.
Separate symptom treatment from fertility treatment; the goals can differ.
Ask what evidence supports any proposed suppression period.
If surgery is proposed, ask how it changes uterine integrity and the timing of pregnancy.
Consider a second opinion if the recommendation would delay treatment for months.

What the diagnosis should answer

Adenomyosis is not simply “endometriosis inside the uterus.” It refers to endometrial-type glands and stroma within the uterine muscle, accompanied by changes in the surrounding myometrium. The practical fertility questions are whether the diagnosis is secure, how extensive the disease appears to be, whether symptoms are significant, and whether another condition such as endometriosis or fibroids is also present.

Question	Why it matters
Diffuse or focal?	Diffuse disease involves broader areas of the myometrium; focal adenomyosis can resemble an adenomyoma and may create different surgical considerations.
Symptoms?	Heavy bleeding, painful periods, chronic pelvic pain and bulk symptoms may influence treatment even apart from fertility.
Ultrasound confidence?	Specialist transvaginal ultrasound can identify characteristic features; MRI may clarify uncertain or complex cases.
Other pathology?	Endometriosis and fibroids can coexist, so a single diagnosis may not explain the entire fertility picture.

How ultrasound language translates

Reports may mention a globular uterus, asymmetric myometrial thickening, myometrial cysts, echogenic islands, fan-shaped shadowing, an irregular junctional zone or translesional vascularity. One feature alone is not a magic diagnostic test. Experienced interpretation and a consistent pattern are more useful than counting isolated signs.

High-value question: “How confident are you that this is adenomyosis, and what finding on my imaging makes you confident?” That separates a meaningful diagnosis from a vague impression on a routine scan.

Why the IVF conversation is nuanced

Observational studies have associated adenomyosis with lower implantation and live-birth rates and higher miscarriage rates in some populations, but the studies vary substantially in diagnostic criteria, disease severity, embryo characteristics and treatment protocols. That makes it difficult to promise that any one pretreatment strategy will reverse the risk.

Long GnRH-agonist suppression before embryo transfer is commonly discussed. Some clinics use it selectively for more extensive disease or repeated implantation failure. However, evidence is not strong enough to say that every patient with adenomyosis should receive months of suppression, and treatment has costs: delay, menopausal-type symptoms, and potential impact on quality of life.

Fresh transfer, freeze-all, or FET?

The presence of adenomyosis can influence whether a clinic prefers to separate ovarian stimulation from embryo transfer. A freeze-all approach may allow the uterus to return to a non-stimulated hormonal environment and creates time for treatment if suppression is chosen. That does not mean freeze-all is mandatory. Embryo quality, ovarian response, symptoms and clinic protocol all matter.

Questions about the uterus

How extensive does the adenomyosis look?
Is there cavity distortion?
Are fibroids or polyps also present?
Is the uterus enlarged or markedly asymmetric?

Questions about timing

Would pretreatment delay matter for ovarian reserve?
Could embryos be created first and the uterus treated later?
What outcome is the proposed suppression expected to improve?
What side effects should be expected?

Surgery has a limited, specialized role

Unlike a polyp or a submucosal fibroid, diffuse adenomyosis does not usually have a simple “remove it and restore the cavity” solution. Conservative surgery may be considered in selected focal disease, severe symptoms or specialized circumstances, but it can be technically difficult and can alter the uterine wall. Anyone considering adenomyosis surgery for fertility should understand the surgeon's experience, uterine reconstruction plan, recovery interval and future pregnancy implications.

Adenomyosis when trying without IVF

If pregnancy has not occurred, the rest of the fertility evaluation still matters. Ovulation, semen analysis, tubal patency, ovarian reserve when indicated, and age-related factors should not be skipped because adenomyosis appears on a scan. A visible uterine diagnosis can become an anchoring bias; the fertility workup still needs to identify all relevant contributors.

Evidence reality check: professional guidance emphasizes improving the consistency of diagnosis because studies still use heterogeneous definitions. Associations with fertility outcomes are real enough to warrant discussion, but there is not a universally proven pretreatment regimen that fits every patient.

Frequently asked questions

Is adenomyosis the same as endometriosis?

No. Endometriosis is endometrial-like tissue outside the uterus; adenomyosis involves the uterine muscle. They can occur together.

Can you get pregnant with adenomyosis?

Yes. Adenomyosis is not a diagnosis of sterility. Its effect varies with severity and other fertility factors.

Does everyone with adenomyosis need suppression before IVF?

No. Practice varies, and treatment should be individualized because evidence does not support one universal protocol.

Sources and evidence checked

Medical disclaimer: This article is for general educational purposes and is not medical advice, diagnosis, or a treatment recommendation. Fertility evaluation and treatment should be individualized with a qualified reproductive endocrinologist, reproductive urologist, gynecologic surgeon, or other appropriate clinician.